Thyroxine vs Thyroxine Plus Triiodothyronine in Treatment of Hypothyroidism After Thyroidectomy for Graves' Disease
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
It was recently demonstrated that treatment with levorotatory thyroxine (T4) plus triiodothyronine (T3) compared with treatment with T4 alone improves psychologic functioning in hypothyroid patients with thyroid cancer or autoimmune thyroiditis. In the present double-blind crossover study, we again compared the effects of combined thyroid replacement vs monotherapy on psychologic function, endocrine function, cardiovascular function, and body composition. The patients were women who were hypothyroid after thyroidectomy for Graves' disease. The substitution of 10 microg of T3 for 50 microg of T4 caused a statistically significant decrease in free T4 concentration but no significant change in T3 or thyroid-stimulating hormone concentration. Symptoms of hypothyroidism and of hyperthyroidism tended to decrease on a standard symptom scale after combined treatment. With combined hormone replacement, mental state tended to improve on some mood scales but not on cognitive tests. We found alterations in left ventricular diastolic function but no change in body composition after the combined treatment regimen. These preliminary findings in a small group of patients with Graves' disease are consistent with earlier findings that thyroid replacement with T4-T3 combination improves mental functioning.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Eleven trials were 5–16 weeks (23,46,49,51–53,58–60,71,79), three trials were 4–6 months (17,48,78), and one trial was 1 year in duration (47).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [51]
In the citing paper
“Echocardiography parameters were basically unaltered in one trial that included this assessment (51).”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [51]
In the citing paper
“This may constitute a bias, as the benefit of combination therapy in one trial was observed only in the thyroid cancer patients and not in patients with autoimmune thyroiditis [48,49] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [48]
In the citing paper
“Patient preference for combination therapy was associated with improvement in QoL, cognition, mood and symptoms in three trials [5,44,48] but absent in two trials [40,46] .”
From 2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism (2012) · cites this paper as [48]
In the citing paper
“Some of these trials did note improvements (or trends towards improvement) in clinical parameters such as diastolic cardiac function 34 , QoL 36,40,50,51 , or lipid profiles 39,53 .”
From A review of the safety of triiodothyronine in combination with levothyroxine for the management of hypothyroidism (2024) · cites this paper as [50]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
WAIS-R manual : Wechsler adult intelligence scale-revised
Wechsler, D. (1981) · Medical Entomology and Zoology · Cited by 1,559
Combined Thyroxine and Triiodothyronine for Thyroid Replacement Therapy
Taylor, S., Kapur, M., & Adie, R. (1970) · BMJ · doi:10.1136/bmj.2.5704.270 · Cited by 44 · cited 2×
“Nevertheless, it has long been noted that after treatment with T4 alone not all patients are entirely well (2).”
Background
Cited by
Jonklaas, J., Bianco, A. C., Bauer, A. J., Burman, K. D., Cappola, A. R., Celi, F. S., Cooper, D. S., Kim, B. W., Peeters, R. P., Rosenthal, M. S., et al. (2014) · Thyroid® · doi:10.1089/thy.2014.0028 · Cited by 1,928
“Among the five blinded, cross-over design trials comparing treatment preference (385,387,517,519,521), combination LT4/LT3 treatment was preferred to LT4 in four trials (387,517,519,521), whereas there was no significant difference in treatment preference in only one trial (385).”
Influential2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 437
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332
Panicker, V., Saravanan, P., Vaidya, B., Evans, J., Hattersley, A. T., Frayling, T. M., & Dayan, C. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1301 · Cited by 327
Grozinsky-Glasberg, S., Fraser, A., Nahshoni, E., Weizman, A., & Leibovici, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0448 · Cited by 296
“Appelhof 2005 (11) Yes A, computer-generated sequence of randomization A, concealed randomization sequence No Double blind SCL-90; POMS; Digit Symbol Test; Digit Span Test (forward and backward) Bunevicius 1999 (12) Yes B, not specified A, prearranged randomization schedule handled by pharmacy No Triple blind BDI; POM…”
BackgroundMethod
Metadata
- Authors
- Bunevicius, R., Jakubonien, N., Jurkevicius, R., Cernicat, J., Lašas, L., & Prange, A. J.
- Affiliations
- Hospital of Lithuanian University of Health Sciences Kaunas Clinics (LT)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Prange, Arthur J
- Venue
- Endocrine
- Published
- 2002
- Volume
- 18
- Issue
- 2
- Pages
- 129-134
- ISSN
- 0969-711X (ISSN-L)
- OpenAlex
- W1997047813
- Cited by
- 111
- References
- 2
- Citations by year
- 2025: 6 · 2024: 7 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 6 · 2019: 9 · 2018: 9 · 2017: 4 · 2016: 7 · 2015: 4 · 2014: 5 · 2013: 2 · 2012: 9
- FWCI
- 1.92
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-03-09)
- Open access
- closed
- Locations
- Endocrine (publishedVersion)
- PubMed (publishedVersion)
- Lithuanian University of Health Sciences (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Keywords
- thyroxine, triiodothyronine, hypothyroidism, Graves' disease, thyroidectomy, free thyroxine, thyroid-stimulating hormone, left ventricular diastolic function, body composition, mood, cognitive function, cardiovascular function
- MeSH terms
- Adult, Drug Therapy, Combination, Female, Graves Disease, Humans, Hypothyroidism, Middle Aged, Thyroidectomy, Thyroxine, Triiodothyronine, Patient Satisfaction, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thyroxine vs Thyroxine Plus Triiodothyronine in Treatment of Hypothyroidism After Thyroidectomy for Graves' Disease. https://app.cochat.ai/papers/10.1385/endo:18:2:129
- The paper
- Bunevicius, R., Jakubonien, N., Jurkevicius, R., Cernicat, J., Lašas, L., & Prange, A. J. (2002). Thyroxine vs Thyroxine Plus Triiodothyronine in Treatment of Hypothyroidism After Thyroidectomy for Graves' Disease. Endocrine. https://doi.org/10.1385/endo%3A18%3A2%3A129
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.